Exploring disease-causing traits for drug repurposing in critically ill COVID-19 patients: A causal inference approach
Description
Despite recent development of vaccines to prevent SARS-CoV-2 infection, treatment of critically ill COVID-19 patients remains an important goal. In principle, genome-wide association studies (GWASs) provide a shortcut to the clinical evidence needed
